# Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer

> **NCT01034332** · PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 58 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** TP-HDFL,TP-CCRT, Esophagectomy

## Key facts

- **NCT ID:** NCT01034332
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-12
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2009-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034332, "Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT01034332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*